GlobeNewswire Inc.Sep 30, 4:56 AM ETNeutral
Listed as market participant but no specific competitive advantages, products, or strategic initiatives mentioned in the article.
Harvard Bioscience news
$7.96−0.25%
Close Sep 29, 2026 · split-adjustedArticles · 30 days1English, de-duplicated
Positive00% of coverage
Neutral1100%
Negative00% of coverage
About Harvard Bioscience
No recent articles focused on Harvard Bioscience.
Also mentions HBIO
Articles that tag HBIO but are mainly about other companies.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology